The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Hormone replacement therapy: Fortnightly review
Open accessAbstract
The number of women who will live half their adult lives after the menopause increases every year.1 A challenging question for doctors is how women should be counselled about postmenopausal oestrogen therapy. #### Summary points Five or more years of postmenopausal oestrogen is the standard of care for the prevention or treatment of osteoporosis; benefit requires continued use Oestrogen increases the risk of endometrial cancer during and after use,unless it is taken with adequate progestogen It probably increases the risk of breast cancer, but only during current use It may reduce the risk of coronary heart disease Routine oestrogen treatment should not be recommended until more risk:benefit data are available from clinical trials This review is based on observations during 25 years of research into women's health, and on Medline searches on oestrogen or menopause. Only recent publications are cited. Unless otherwise stated, oestrogen therapy refers to treatment of postmenopausal women with pharmacological doses of oral oestrogen taken alone or with an oral progestogen. About 75% of women in English speaking countries experience no troublesome symptoms during the menopause transition.2 Population studies have shown that symptoms are less common or different in other countries, and more common and more severe after an induced menopause. Hot flushes and night sweats are the only symptoms universally reported to respond (usually almost immediately) to oestrogen. Without treatment, hot flushes typically disappear within 1-2 years, but in some untreated women they continue for more than 20 years. After the menopause the vaginal wall becomes thinner and less vascular, changes which may be accompanied by vaginal dryness and dyspareunia. Intravaginal oestrogen prevents and treats these symptoms and also reduces the risk of recurrent urinary tract infection, probably by modifying the vaginal flora.3 Urinary incontinence, which becomes more common with increasing age, is not usually improved …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women
Grady, D., Rubin, S. M., Petitti, D. B., Fox, C. S., Black, D., Ettinger, B., Ernster, V. L., & Cummings, S. R. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-12-1016 · Cited by 2,336
Valery (1995) · doi:10.1001/jama.1995.03520270033028 · Cited by 2,320
Postmenopausal Hormone Therapy and Mortality
Grodstein, F., Stampfer, M. J., Colditz, G. A., Willett, W. C., Manson, J. E., Joffe, M., Rosner, B., Fuchs, C., Hankinson, S. E., Hunter, D. J., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199706193362501 · Cited by 1,184
Walsh, B. W., Schiff, I., Rosner, B., Greenberg, L., Ravnikar, V., & Sacks, F. M. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110243251702 · Cited by 1,152
Research on the menopause in the 1990s. Report of a WHO Scientific Group.
(1996) · PubMed · Cited by 1,144
Boyd, N. F., Byng, J. W., Jong, R. A., Fishell, E. K., Little, L. E., Miller, A. B., Lockwood, G. A., Tritchler, D. L., & Yaffe, M. J. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.9.670 · Cited by 1,105
Hormone replacement therapy and endometrial cancer risk: A meta-analysis
GRADY, D., GEBRETSADIK, T., KERLIKOWSKE, K., ERNSTER, V, & PETITTI, D. (1995) · Obstetrics & Gynecology · doi:10.1016/0029-7844(94)00383-o · Cited by 962
Estrogen Therapy in Postmenopausal Women: Effects on Cognitive Function and Dementia
Yaffe, K., Sawaya, G., Lieberburg, I., & Grady, D. (1998) · JAMA · doi:10.1001/jama.279.9.688 · Cited by 941
Raz, R., & Stamm, W. E. (1993) · New England Journal of Medicine · doi:10.1056/nejm199309093291102 · Cited by 928
Treatment of Postmenopausal Osteoporosis with Transdermal Estrogen
Lufkin, E. G., Wahner, H. W., O'Fallon, W. M., Hodgson, S. F., Kotowicz, M. A., Lane, A. W., Judd, H. L., Caplan, R. H., & Riggs, B. L. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-1-1 · Cited by 810
Miller, V. T., LaRosa, J. C., Barnabei, V. M., Kessler, C. M., Levin, G., Smith-Roth, A., Griffin, M. E., Stoy, D. B., Bush, T. L., Zacur, H. A., et al. (1995) · JAMA · doi:10.1001/jama.273.3.199 · Cited by 601
Self-citationHORMONE REPLACEMENT THERAPY, HEART DISEASE, AND OTHER CONSIDERATIONS
Barrett-Connor, E., & Grady, D. (1998) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.19.1.55 · Cited by 590
Self-citationPostmenopausal Bone Loss Is Prevented by Treatment with Low-Dosage Estrogen with Calcium
ETTINGER, B., GENANT, H. K., & CANN, C. E. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-1-40 · Cited by 531
Beresford, S. A., Weiss, N. S., Voigt, L. F., & McKnight, B. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07365-5 · Cited by 446
Fantl, J. A., Cardozo, L., & McClish, D. K. (1994) · PubMed · Cited by 337
Estrogen-Progestin Replacement Therapy and Endometrial Cancer
Pike, M. C., Peters, R. K., Cozen, W., Probst-Hensch, N. M., Wan, P. C., Mack, T. M., & Felix, J. C. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.15.1110 · Cited by 315
Heart and Estrogen/progestin Replacement Study (HERS)
Grady, D., Applegate, W., Bush, T., Furberg, C., Riggs, B., & Hulley, S. B. (1998) · Controlled Clinical Trials · doi:10.1016/s0197-2456(98)00010-5 · Cited by 260
Hemminki, E., & McPherson, K. (1997) · BMJ · doi:10.1136/bmj.315.7101.149 · Cited by 253
Effect of Estrogen Replacement Therapy on the Specificity and Sensitivity of Screening Mammography
Laya, M. B., Larson, E. B., Taplin, S. H., & White, E. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.10.643 · Cited by 243
Calcium potentiates the effect of estrogen and calcitonin on bone mass: review and analysis
Nieves, J., Komar, L., Cosman, F., & Lindsay, R. (1998) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/67.1.18 · Cited by 243
Postmenopausal Hormone Use and Risk of Large-Bowel Cancer
Newcomb, P. A., & Storer, B. E. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.14.1067 · Cited by 230
Genant, H. K. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440430091011 · Cited by 228
A population based survey of women's experience of the menopause
Porter, M., Penney, G. C., Russell, D., Russell, E., & Templeton, A. (1996) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1996.tb09555.x · Cited by 197
(1996) · JAMA · doi:10.1001/jama.276.17.1389 · Cited by 196
Timing of postmenopausal estrogen for optimal bone mineral density. The Rancho Bernardo Study
Schneider, D. L. (1997) · JAMA · doi:10.1001/jama.277.7.543 · Cited by 187
Myth and paradox of coronary risk and the menopause
Tunstall-Pedoe, H. (1998) · The Lancet · doi:10.1016/s0140-6736(97)11321-6 · Cited by 178
Potshuma, W. F. M., Westendorp, R. G. J., & Vandenbroucke, J. P. (1994) · BMJ · doi:10.1136/bmj.308.6939.1268 · Cited by 162
Hormone replacement therapy and risk of non-fatal stroke
Pedersen, A. T., Lidegaard, Ø., Kreiner, S., & Ottesen, B. (1997) · The Lancet · doi:10.1016/s0140-6736(97)06005-4 · Cited by 142
Estrogen replacement therapy and stroke
Paganini‐Hill, A. (1995) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(95)80014-x · Cited by 138
Quality of life after the menopause: Influence of hormonal replacement therapy
Limouzin-Lamothe, M.-A., Mairon, N., Joyce, C. R. B., & Gal, M. L. (1994) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(94)70239-x · Cited by 130
Venous Thromboembolic Events Associated With Hormone Replacement Therapy
Grady, D. G., Hulley, S. B., & Furberg, C. (1997) · JAMA · doi:10.1001/jama.1997.03550060053030 · Cited by 94
Estrogen Replacement Therapy and Mortality Among Older Women: The Study of Osteoporotic Fractures
Cauley, J. A., Seeley, D. G., Browner, W. S., Ensrud, K., Kuller, L. H., Lipschutz, R. C., & Hulley, S. B. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440400031004 · Cited by 92
Estrogen Replacement Therapy and Prognosis after First Myocardial Infarction
Newton, K. M., LaCroix, A. Z., McKnight, B., Knopp, R. H., Siscovick, D. S., Heckbert, S. R., & Weiss, N. S. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009100 · Cited by 90
Increased risk of cholecystectomy in users of supplemental estrogen
Petitti, D. B., Sidney, S. S., & Perlman, J. A. (1988) · Gastroenterology · doi:10.1016/0016-5085(88)90614-2 · Cited by 84
O’Brien, J. E., Peterson, E. D., Keeler, G. P., Berdan, L. G., Ohman, E. M., Faxon, D. P., Jacobs, A. K., Topol, E. J., & Califf, R. M. (1996) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00306-3 · Cited by 81
Estrogens, the menopause, and osteoporosis
Kanis, J. A. (1996) · Bone · doi:10.1016/s8756-3282(96)90163-5 · Cited by 73
Randomized Trial of Osteoporosis Screening
Torgerson, D. J. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.157.18.2121 · Cited by 55
Women's hearts are hard to break
Newnham, H. H., & Silberberg, J. S. (1997) · The Lancet · doi:10.1016/s0140-6736(97)90002-7 · Cited by 26
Cited by
Best care at lower cost: the path to continuously learning health care in America
(2014) · Choice Reviews Online · doi:10.5860/choice.51-3277 · Cited by 1,363
Breast Cancer Risk After Bilateral Prophylactic Oophorectomy in BRCA1 Mutation Carriers
Rebbeck, T. R., Levin, A. M., Eisen, A., Snyder, C., Watson, P., Cannon-Albright, L., Isaacs, C., Olopade, O., Garber, J. E., Godwin, A. K., et al. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.17.1475 · Cited by 672
Cohort Profile: The Australian Longitudinal Study on Women's Health
Lee, C. (2005) · International Journal of Epidemiology · doi:10.1093/ije/dyi098 · Cited by 660
Insulin resistance and sarcopenia: mechanistic links between common co-morbidities
Cleasby, M. E., Jamieson, P. M., & Atherton, P. J. (2016) · Journal of Endocrinology · doi:10.1530/joe-15-0533 · Cited by 596
Hormone therapy for preventing cardiovascular disease in post-menopausal women
Boardman, H. M., Hartley, L., Eisinga, A., Main, C., Roqué i Figuls, M., Bonfill Cosp, X., Gabriel Sanchez, R., & Knight, B. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002229.pub4 · Cited by 612
Metadata
- Authors
- Barrett-Connor, E.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 1998-08-15
- Volume
- 317
- Issue
- 7156
- Pages
- 457-461
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2762603006
- Cited by
- 403
- References
- 41
- FWCI
- 30.24
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.